Breaking news: $JNJ is keeping its #VerbSurgical robot, for general surgery, under wraps for longer. Company revealed in Q2 earning call it is not pursuing #FDAclearance and is aiming for #FirstInMan trial in H2 2022 #surgicalrobotics